Cytotoxic Activity of Nisin on Human Cancer Cell Lines: A Systematic Review
Novelty in Biomedicine,
Vol. 10 No. 3 (2022),
19 August 2022
Cancer is one of the leading causes of mortality and morbidity worldwide. Nisin consists of various and uncommon amino acids as an antimicrobial protein synthesized by the Lactobacilli genus. The current systematic review aimed to evaluate the anticancer activity of Nisin, an antibacterial peptide, on different human cancer cell lines. We searched PubMed/Medline and Embase databases to detect the studies addressing the cytotoxic activity of Nisin on human cancer cell lines. Our study was conducted following the "PRISMA" guideline. Of 202 potentially relevant articles, 15 studies met the inclusion criteria and were included for further analysis. The results revealed that Nisin has different levels of anticancer activity on human cancer cell lines. The outcomes of our review indicate that some cancer cell lines, such as cell skin carcinoma (A431), Melanoma cells (A375), and colorectal cancer cell lines (LS180), are strongly affected by the anticancer properties of Nisin. In contrast, the anticancer effect of Nisin on others like Human promyelocytic leukemia (HL60) is lower. Nisin shows significant anticancer effects in different cancer cell lines. Utilizing Nisin simultaneously with other antitumor agents can enhance its anticancer features and efficacy. Further studies, especially in vivo assay and clinical trials, are recommended to achieve more accurate results in this field.
- Nisin, Cancer treatment, Systematic review, Cytotoxic activity, Cell line
How to Cite
Torre LA, Bray F, Siegel RL, Ferlay J, Lortet‐Tieulent J, Jemal A. Global cancer statistics, 2012. CA: a cancer journal for clinicians. 2015;65(2):87-108.
Langie SA, Koppen G, Desaulniers D, Al-Mulla F, Al-Temaimi R, Amedei A, et al. Causes of genome instability: the effect of low dose chemical exposures in modern society. Carcinogenesis. 2015;36(Suppl_1):S61-S88.
t3. Corrie PG. Cytotoxic chemotherapy: clinical aspects. Medicine. 2008;36(1):24-8.
Curran S, Vantangoli MM, Boekelheide K, Morgan JR. Architecture of chimeric spheroids controls drug transport. Cancer Microenvironment. 2015;8(2):101-9.
Shilova ON, Shilov ES, Lieber A, Deyev SM. Disassembling a cancer puzzle: Cell junctions and plasma membrane as targets for anticancer therapy. Journal of controlled release. 2018;286:125-36.
Cotter PD, Hill C, Ross RP. Bacteriocins: developing innate immunity for food. Nature Reviews Microbiology. 2005;3(10):777-88.
Servin AL. Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens. FEMS microbiology reviews. 2004;28(4):405-40.
Joo NE, Ritchie K, Kamarajan P, Miao D, Kapila YL. Nisin, an apoptogenic bacteriocin and food preservative, attenuates HNSCC tumorigenesis via CHAC 1. Cancer medicine. 2012;1(3):295-305.
Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2010;8(5):336-41.
Fidler MM, Bray F, Soerjomataram I. The global cancer burden and human development: A review. Scandinavian Journal of public health. 2018;46(1):27-36.
Luqmani Y. Mechanisms of drug resistance in cancer chemotherapy. Medical principles and practice. 2005;14(Suppl. 1):35-48.
Hoskin DW, Ramamoorthy A. Studies on anticancer activities of antimicrobial peptides. Biochimica et Biophysica Acta (BBA)-Biomembranes. 2008;1778(2):357-75.
Farkas-Himsley H, Zhang Y, Yuan M, Musclow C. Partially purified bacteriocin kills malignant cells by apoptosis: programmed cell death. Cellular and molecular biology (Noisy-le-Grand, France). 1992;38(5-6):643-51.
Klaenhammer T, Fremaux C, Ahn C, Milton K. Molecular biology of bacteriocins produced by Lactobacillus. Bacteriocins of lactic acid bacteria: Elsevier; 1993. p. 151-80.
Ahmadi S, Ghollasi M, Hosseini HM. The apoptotic impact of nisin as a potent bacteriocin on the colon cancer cells. Microbial pathogenesis. 2017;111:193-7.
de Arauz LJ, Jozala AF, Mazzola PG, Penna TCV. Nisin biotechnological production and application: a review. Trends in Food Science & Technology. 2009;20(3-4):146-54.
Karpiński TM, Adamczak A. Anticancer activity of bacterial proteins and peptides. Pharmaceutics. 2018;10(2):54.
Giffard C, Ladha S, Mackie A, Clark D, Sanders D. Interaction of nisin with planar lipid bilayers monitored by fluorescence recovery after photobleaching. The Journal of membrane biology. 1996;151(3):293-300.
Gasparoni A, Fonzi L, Schneider G, Wertz P, Johnson G, Squier C. Comparison of differentiation markers between normal and two squamous cell carcinoma cell lines in culture. Archives of oral biology. 2004;49(8):653-64.
Tripathi P, Kamarajan P, Somashekar BS, MacKinnon N, Chinnaiyan AM, Kapila YL, et al. Delineating metabolic signatures of head and neck squamous cell carcinoma: phospholipase A2, a potential therapeutic target. The international journal of biochemistry & cell biology. 2012;44(11):1852-61.
Dobrzyńska I, Skrzydlewska E, Figaszewski ZA. Changes in electric properties of human breast cancer cells. The Journal of membrane biology. 2013;246(2):161-6.
Yamaji-Hasegawa A, Tsujimoto M. Asymmetric distribution of phospholipids in biomembranes. Biological and Pharmaceutical Bulletin. 2006;29(8):1547-53.
Paiva AD, de Oliveira MD, de Paula SO, Baracat-Pereira MC, Breukink E, Mantovani HC. Toxicity of bovicin HC5 against mammalian cell lines and the role of cholesterol in bacteriocin activity. Microbiology. 2012;158(11):2851-8.
Preet S, Bharati S, Panjeta A, Tewari R, Rishi P. Effect of nisin and doxorubicin on DMBA-induced skin carcinogenesis—a possible adjunct therapy. Tumor biology. 2015;36(11):8301-8.
Zhao J, Huang Y, Liu D, Chen Y. Two hits are better than one: synergistic anticancer activity of α-helical peptides and doxorubicin/epirubicin. Oncotarget. 2015;6(3):1769.
Begde D, Bundale S, Mashitha P, Rudra J, Nashikkar N, Upadhyay A. Immunomodulatory efficacy of nisin—a bacterial lantibiotic peptide. Journal of peptide science. 2011;17(6):438-44.
Murinda S, Rashid K, Roberts RF. In vitro assessment of the cytotoxicity of nisin, pediocin, and selected colicins on simian virus 40–transfected human colon and Vero monkey kidney cells with trypan blue staining viability assays. Journal of food protection. 2003;66(5):847-53.
Cruz-Chamorro L, Puertollano MA, Puertollano E, de Cienfuegos GÁ, de Pablo MA. In vitro biological activities of magainin alone or in combination with nisin. Peptides. 2006;27(6):1201-9.
Goodarzi F, Asadi A, Zahri S. Cytotoxicity of Nisin on Human Gastric Carcinoma (AGS) Cell Line. New Cellular and Molecular Biotechnology Journal. 2013;3(10):9-13.
Kamarajan P, Hayami T, Matte B, Liu Y, Danciu T, Ramamoorthy A, et al. Nisin ZP, a bacteriocin and food preservative, inhibits head and neck cancer tumorigenesis and prolongs survival. PloS one. 2015;10(7):e0131008.
Lewies A, Wentzel JF, Miller HC, Du Plessis LH. The antimicrobial peptide nisin Z induces selective toxicity and apoptotic cell death in cultured melanoma cells. Biochimie. 2018;144:28-40.
Avand A, Akbari V, Shafizadegan S. In vitro cytotoxic activity of a Lactococcus lactis antimicrobial peptide against breast cancer cells. Iranian journal of biotechnology. 2018;16(3).
Zainodini N, Hassanshahi G, Hajizadeh M, Falahati-Pour SK, Mahmoodi M, Mirzaei MR. Nisin induces cytotoxicity and apoptosis in human asterocytoma cell line (SW1088). Asian Pacific journal of cancer prevention: APJCP. 2018;19(8):2217.
Norouzi Z, Salimi A, Halabian R, Fahimi H. Nisin, a potent bacteriocin and anti-bacterial peptide, attenuates expression of metastatic genes in colorectal cancer cell lines. Microbial pathogenesis. 2018;123:183-9.
Goudarzi F, Asadi A, Afsharpour M, Jamadi RH. In vitro characterization and evaluation of the cytotoxicity effects of nisin and nisin-loaded PLA-PEG-PLA nanoparticles on gastrointestinal (AGS and KYSE-30), hepatic (HepG2) and blood (K562) cancer cell lines. AAPS PharmSciTech. 2018;19(4):1554-66.
Prince A, Tiwari A, Ror P, Sandhu P, Roy J, Jha S, et al. Attenuation of neuroblastoma cell growth by nisin is mediated by modulation of phase behavior and enhanced cell membrane fluidity. Physical Chemistry Chemical Physics. 2019;21(4):1980-7.
Rana K, Sharma R, Preet S. Augmented therapeutic efficacy of 5-fluorouracil in conjunction with lantibiotic nisin against skin cancer. Biochemical and biophysical research communications. 2019;520(3):551-9.
Sasani N, Roghanian R, Emtiazi G, Aghaie A. A Novel Approach on Leukodepletion Filters: Investigation of Synergistic Anticancer Effect of Purified α-Defensins and Nisin. Advanced Pharmaceutical Bulletin. 2021;11(2):378.
Hosseini SS, Hajikhani B, Faghihloo E, Goudarzi H. Increased expression of caspase genes in colorectal cancer cell line by nisin. Archives of Clinical Infectious Diseases. 2020;15(2).
- Abstract Viewed: 189 times
- pdf Downloaded: 118 times